OVN
Director Trades
| Date | Director | Value | 
|---|
Company News

Oventus looks to boost uptake of O2Vent technology with Aeroflow
Medical device company Oventus Medical (ASX: OVN) has confirmed its sleep treatment platform will be included in a range of obstructive sleep apnoea (OSA) treatment solutions being sold by Aeroflow Healthcare, a US durable medical equipment supply business. Under the terms of the agreement, Oventus’ platform, including its O2Vent Optima product and consumables will be introduced […]

Oventus Medical launches three additional ‘lab in lab’ sites in the US
Medical device company Oventus Medical (ASX: OVN) has launched a further three clinical delivery sites in the US as part of its “lab in lab” business model while confirming that its initial five sites generated first revenues in December 2019. Three new sites are now operational in South Carolina, Illinois and Texas, with all three expected […]

Oventus Medical gets set for US market after FDA approval for O2Vent Optima
Medical device company Oventus Medical (ASX: OVN) has received a major boost in its bid to see the O2Vent Optima oral device being sold across the US. Earlier today, Oventus announced that it had received regulatory clearance from the US Food and Drug Administration (FDA) for O2Vent Optima – the newest product in the O2Vent oral […]

Oventus Medical to roll-out sleep apnoea treatment across US sleep clinics
A further two US sleep medicine groups have agreed to adopt Oventus Medical’s (ASX: OVN) O2Vent sleep technology to treat obstructive sleep apnoea at their facilities. Delaware Sleep Disorder Centres and Reliable Respiratory will roll-out Oventus’ O2Vent sleep treatment platform and lab in lab business model across a total of 10 facilities. “It is very […]

Oventus launches new oral device to treat obstructive sleep apnoea
Queensland-based Oventus Medical (ASX: OVN) has released what it believes to be “an important addition” to its line-up of oral devices designed to assist patients with obstructive sleep apnoea. The O2Vent Optima is a customised oral appliance designed to reduce airway collapsibility and manage mouth breathing, with or without a nasal continuous positive airway pressure […]

Oventus Medical ExVent device gives PEEP at future for obstructive sleep apnoea patients
Mel Bridges-chaired Oventus Medical’s (ASX: OVN) newly developed ExVent PEEP valve has successfully treated obstructive sleep apnoea patients in conjunction with the company’s existing O2Vent appliance, without the need for continuous positive-airway-pressure (CPAP) during an ongoing clinical study. Oventus has been developing the O2Vent and associated accessories to treat obstructive sleep apnoea without a mask. […]
Company Videos
No videos found.